N b -Acyl-and N b -acyl-1-hydroxytryptamines are found to be novel and structurally simple α 2 -blocker for the treatment of erectile dysfunction. Nowadays, a lot of people need a drug for the treatment of erectile dysfunction (ED). Sildenafil citrate (1, R O OH 6 5 RCO 2 H Carboxylic Acid 5 7 8 9 *1: reacted at around 60 °C for 1 h.
) has been used as a promising drug, but it has some side-effects 2 to be improved. Although yohimbine 3 (2) is a folk medicine and widely used among people as a α 2 -blocker to treat ED, it is a powerful medicine and dangerous unless we are careful about quantity to take. Therefore, when the safer drug is found, it would not only bring happiness to a human being, but also be applied for raising the breeding rate of animals. 4, 5 Cows and pigs could lay a lot of calves and child pigs, respectively and offer meat to us solving the significant problem of food shortage in the world. In our project for developing a novel and potent α 2 -blocker, structurally simpler than 1 and 2, we discovered that N b -acetyl-(3a) and N b -methoxycarbonyltryptamines (3b) have weak but reliable activity as a α 2 -blocker. 4 On the other hand, we succeeded in the establishment of 1-hydroxyindole chemistry. 5
As a result, we found that 1-hydroxy-N b -methoxycarbonyltryptamine (3c: IC 50 0.32 μM) is one of the best leads and ten times more potent than cilostazol (4: IC 50 3.10 μM) in the inhibition test on arachidonic acid induced platelet aggregation in rabbit PRP. 6 It is expected to be a possible lead for cerebral and myocardial infarction. 7 We attempted therefore to pursue the study of structure-activity relationship of N b -acyltryptamines and their 1-hydroxytryptamine derivatives hoping to develop a potent lead for ED and cerebral infarction.
For the preparation of N b -acyltryptamines, a conventional mixed anhydride method was applied.
Appropriate carboxylic acids (5, Table 1 ) were treated with methyl chloroformate. The resultant anhydrides were then reacted with tryptamine (6) to afford the desired compounds (7) and the results are summarized in Table 1 . Employing propanoic (5a), pentanoic (5b), heptanoic (5c), and nonanoic acids With the desired compounds in hand, we next evaluated the relaxant potencies of 7b-e and 9b-e as a preliminary test. The extent of the vascular relaxation produced in the muscle contracted with clonidine is summarized in Figure 1 , making the activity of yohimbine as a standard for 100. It is interesting to note that the activity increases depending on the length of N b -acyl side chain. 5e, 8 In addition, differences in activities are small between N(1)-H (7b-e) and N(1)-OH compounds (9b-e). These results strongly suggest that these simple tryptamine derivatives possess at least the antagonistic effect on vascular smooth muscle α 2 -AR. 8 The potencies of 7d and 9d reached to about 80% of that of yohimbine.
Furthermore, LD 50 of 7d was determined to be more than 80 mg/kg on ddy male mouse, showing its safety. The details will be reported elsewhere in due course.
In conclusion, we have succeeded in finding new leads for the treatment of ED. We named them SST-VED-I type compounds. In order to discover more potent α 2 -blocker, we are preparing tryptamines having various N b -side chain. The biological evaluation concerning cerebral infarction is now in progress.
EXPERIMENTAL
Melting points were determined on a Yanagimoto micro melting point apparatus and are uncorrected.
Infrared (IR) spectra were recorded with a Shimadzu IR-420 and proton nuclear magnetic resonance 
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